ciprofloxacin has been researched along with albendazole in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Agarwal, MR; Goel, MC; Misra, A | 1 |
Abraham, MH; Mitchell, RC; Takács-Novák, K | 1 |
Aksoy, U; Usluca, S | 1 |
Bhat, SA; Kareem, A; Khan, MS; Mirza, AU; Mohammad, A; Nami, SAA; Nishat, N; Singh, P | 1 |
1 review(s) available for ciprofloxacin and albendazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for ciprofloxacin and albendazole
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Percutaneous drainage of renal hydatid cyst: early results and follow-up.
Topics: Adult; Albendazole; Ciprofloxacin; Drainage; Echinococcosis; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Nephrostomy, Percutaneous; Praziquantel; Renal Insufficiency; Urinary Catheterization | 1995 |
On the partition of ampholytes: application to blood-brain distribution.
Topics: Albendazole; Anti-Infective Agents; Blood-Brain Barrier; Buffers; Ciprofloxacin; Cyclohexanes; Fluoroquinolones; Hydrogen-Ion Concentration; Morphine; Niflumic Acid; Nitrazepam; Octanols; Pharmaceutical Preparations; Solubility; Structure-Activity Relationship; Sulfamethazine; Water | 1997 |
[Microsporidium spp. infection in an immunocompromised child diagnosed by polymerase chain reaction].
Topics: Albendazole; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Therapy, Combination; Feces; Humans; Immunocompromised Host; Male; Microsporidia, Unclassified; Microsporidiosis; Myotonic Dystrophy; Shigella | 2010 |
Biomediated synthesis, characterization, and biological applications of nickel oxide nanoparticles derived from Toona ciliata, Ficus carica and Pinus roxburghii.
Topics: Albendazole; Biotechnology; Ciprofloxacin; Ficus; Gentamicins; Green Chemistry Technology; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Nickel; Oxygen; Particle Size; Pinus; Plant Extracts; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Temperature; Thermogravimetry; Toona; X-Ray Diffraction | 2021 |